Regional anesthesia

Efficacy and safety of ketamine as an adjuvant to regional anesthesia: A systematic review and meta-analysis of randomized controlled trials

J Clin AnesthPublished Systematic review and meta-analysis of randomised trials

Pooled result · Duration of analgesiaResult — go to the resultMD 172.21 min 95% CI 118.20–226.22

Authors' conclusion

This study indicates that ketamine could be an ideal adjuvant to local anesthetics regardless of the types of anesthesia. Overall, the quality of the evidence is low.

Study context

Population
ASA I–II patients undergoing surgery or procedures under regional anesthesia, with or without GA
Participants
1,011 patients · 20 RCTs
Comparison
Ketamine added to local anaesthetic in RA vs no ketamine
Outcome
Duration of analgesia
Methodological detailsCochrane risk of bias tool, Grading of Recommendations, Assessment, Development and Evaluations (GRADE), Overall quality of evidence low (GRADE)
  • Cochrane risk of bias tool
  • GRADE
  • Overall quality of evidence low (GRADE)

Pooled result

As reported in the abstract

MD

172.21 min

95% CI 118.20–226.22

P < 0.00001

Ketamine vs No ketamine
MD 172.21 min (95% CI 118.20–226.22); P < 0.00001

Further pooled results

OutcomeMD (min) (95% CI)P value
Duration of analgesia, peripheral nerve block (subgroup)I2 = 98%366.96 (154.19–579.74)P = 0.0007
Duration of sensory blockI2 = 96%29.12 (10.22–48.01)P = 0.003
Duration of motor blockI2 = 84%6.94 (−2.65 to 16.53)P = 0.16
Motor block onset timeI2 = 100%−1.17 (−2.67 to 0.34)P = 0.13
Sensory block onset timeI2 = 96%−0.33 (−0.87 to 0.20)P = 0.23

Safety

OutcomeOR (95% CI)P value
Ketamine-related adverse effectsI2 = 57%1.97 (0.93–4.17)P = 0.08

Original publication

Efficacy and safety of ketamine as an adjuvant to regional anesthesia: A systematic review and meta-analysis of randomized controlled trials. J Clin Anesth. Published 23 February 2024. doi:10.1016/j.jclinane.2024.111415

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.